Bowden RA - Search Results

1

A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.

Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W. Bowden RA, et al. Blood. 1995 Nov 1;86(9):3598-603. Blood. 1995. PMID: 7579469 Free article. Clinical Trial.

2

The risk of transmitting cytomegalovirus infection by fresh frozen plasma.

Bowden R, Sayers M. Bowden R, et al. Transfusion. 1990 Oct;30(8):762-3. doi: 10.1046/j.1537-2995.1990.30891020340.x. Transfusion. 1990. PMID: 2171162

3

Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant.

Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD. Bowden RA, et al. Blood. 1991 Jul 1;78(1):246-50. Blood. 1991. PMID: 1648976 Free article. Clinical Trial.

4

Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant.

Bowden RA, Fisher LD, Rogers K, Cays M, Meyers JD. Bowden RA, et al. J Infect Dis. 1991 Sep;164(3):483-7. doi: 10.1093/infdis/164.3.483. J Infect Dis. 1991. PMID: 1651360 Clinical Trial.

5

Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks.

Bowden RA, Sayers M, Gleaves CA, Banaji M, Newton B, Meyers JD. Bowden RA, et al. Transfusion. 1987 Nov-Dec;27(6):478-81. doi: 10.1046/j.1537-2995.1987.27688071699.x. Transfusion. 1987. PMID: 2825381

6

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant.

Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Goodrich JM, et al. Among authors: bowden ra. Ann Intern Med. 1993 Feb 1;118(3):173-8. doi: 10.7326/0003-4819-118-3-199302010-00003. Ann Intern Med. 1993. PMID: 8380242 Clinical Trial.

7

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study.

Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. Boeckh M, et al. Among authors: bowden ra. Blood. 1996 Nov 15;88(10):4063-71. Blood. 1996. PMID: 8916975 Free article. Clinical Trial.

8

Supportive care of the marrow transplant recipient: the Seattle Experience.

Sullivan KM, Meyers J, Petersen FB, Bowden R, Counts GC, Banaji M, Schubert M, Clark J, Clift RA, Appelbaum FR, et al. Sullivan KM, et al. Among authors: bowden r. Haematol Blood Transfus. 1990;33:539-45. doi: 10.1007/978-3-642-74643-7_96. Haematol Blood Transfus. 1990. PMID: 2182446 Review.

9

Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.

Clift RA, Buckner CD, Thomas ED, Bryant E, Anasetti C, Bensinger WI, Bowden R, Deeg HJ, Doney KC, Fisher LD, et al. Clift RA, et al. Among authors: bowden r. Blood. 1994 Dec 15;84(12):4368-73. Blood. 1994. PMID: 7527674 Free article. Review.

10

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.

Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, Deeg HJ, Doney KC, Fisher LD, Hansen JA, et al. Clift RA, et al. Among authors: bowden r. Blood. 1994 Sep 15;84(6):2036-43. Blood. 1994. PMID: 8081005 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters